Form 4: Myriad Genetics Executive Natalie Munk Reports Stock Transaction

Natalie Munk, Chief Accounting Officer of Myriad Genetics, reports the disposal of 217 common stock shares to cover tax obligations related to vesting restricted stock units.

Summary

• On August 25, 2024, Natalie Munk, the Chief Accounting Officer of Myriad Genetics Inc., reported a transaction involving the company's common stock.
• Munk disposed of 217 shares of common stock at a price of $28.12 per share to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Munk directly owns 44,223 shares of Myriad Genetics Inc.
• The transaction was executed under transaction code 'F', indicating that the shares were withheld by the company to cover tax obligations.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a routine stock transaction for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.

Key Dates